Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma
Clinical trial NCT00379080 · COMPLETED
Trial details
- NCT number
- NCT00379080
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2012-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.